Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and two have issued a strong buy recommendation on the company.
Several research firms recently commented on RBGLY. Royal Bank Of Canada cut Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research note on Monday, October 27th. Jefferies Financial Group reiterated a “hold” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Citigroup assumed coverage on shares of Reckitt Benckiser Group in a report on Wednesday, January 14th. They issued a “buy” rating for the company. Finally, Morgan Stanley lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Monday, December 15th.
Read Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Up 1.3%
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- The day the gold market broke
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
